Kowalczyk A et al. |
Insights into novel anticancer applications for apigenin. |
2017 |
Adv Clin Exp Med |
pmid:29211364
|
Zhong Y et al. |
Apigenin attenuates patulin-induced apoptosis in HEK293 cells by modulating ROS-mediated mitochondrial dysfunction and caspase signal pathway. |
2017 |
Toxicon |
pmid:28734981
|
Hicks DF et al. |
Transcriptome-based repurposing of apigenin as a potential anti-fibrotic agent targeting hepatic stellate cells. |
2017 |
Sci Rep |
pmid:28256512
|
Perrott KM et al. |
Apigenin suppresses the senescence-associated secretory phenotype and paracrine effects on breast cancer cells. |
2017 |
Geroscience |
pmid:28378188
|
Stump TA et al. |
The antiproliferative and apoptotic effects of apigenin on glioblastoma cells. |
2017 |
J. Pharm. Pharmacol. |
pmid:28349530
|
Sun XP et al. |
Scutellarin protects against doxorubicin-induced acute cardiotoxicity and regulates its accumulation in the heart. |
2017 |
Arch. Pharm. Res. |
pmid:28315259
|
Ferrazzi P et al. |
Pollination effects on antioxidant content of Perilla frutescens seeds analysed by NMR spectroscopy. |
2017 |
Nat. Prod. Res. |
pmid:28278651
|
Granato M et al. |
Apigenin, by activating p53 and inhibiting STAT3, modulates the balance between pro-apoptotic and pro-survival pathways to induce PEL cell death. |
2017 |
J. Exp. Clin. Cancer Res. |
pmid:29179721
|
Fan H et al. |
Scutellarin Prevents Nonalcoholic Fatty Liver Disease (NAFLD) and Hyperlipidemia via PI3K/AKT-Dependent Activation of Nuclear Factor (Erythroid-Derived 2)-Like 2 (Nrf2) in Rats. |
2017 |
Med. Sci. Monit. |
pmid:29172017
|
Gu C et al. |
Preparation of Vitexin Nanoparticles by Combining the Antisolvent Precipitation and High Pressure Homogenization Approaches Followed by Lyophilization for Dissolution Rate Enhancement. |
2017 |
Molecules |
pmid:29165376
|
Britto SM et al. |
Apigenin prevents ultraviolet-B radiation induced cyclobutane pyrimidine dimers formation in human dermal fibroblasts. |
2017 |
Mutat. Res. |
pmid:28735741
|
Jangdey MS et al. |
Fabrication, in-vitro characterization, and enhanced in-vivo evaluation of carbopol-based nanoemulsion gel of apigenin for UV-induced skin carcinoma. |
2017 |
Drug Deliv |
pmid:28687053
|
Perez-Leal O et al. |
Pharmacological stimulation of nuclear factor (erythroid-derived 2)-like 2 translation activates antioxidant responses. |
2017 |
J. Biol. Chem. |
pmid:28684421
|
Chen JL and Ko WC |
Relaxation of isolated guinea-pig trachea by apigenin, a constituent of celery, via inhibition of phosphodiesterase. |
2017 |
Eur. J. Pharmacol. |
pmid:28603044
|
Karim R et al. |
Development and evaluation of injectable nanosized drug delivery systems for apigenin. |
2017 |
Int J Pharm |
pmid:28456651
|
Erdogan S et al. |
The natural flavonoid apigenin sensitizes human CD44 prostate cancer stem cells to cisplatin therapy. |
2017 |
Biomed. Pharmacother. |
pmid:28107698
|
Thirusangu P et al. |
Scutellarein antagonizes the tumorigenesis by modulating cytokine VEGF mediated neoangiogenesis and DFF-40 actuated nucleosomal degradation. |
2017 |
Biochem. Biophys. Res. Commun. |
pmid:28104392
|
Pápay ZE et al. |
Controlled Release Oral Delivery of Apigenin Containing Pellets with Antioxidant Activity. |
2017 |
Curr Drug Deliv |
pmid:27264725
|
Wang J et al. |
Novel cationic lipid nanoparticles as an ophthalmic delivery system for multicomponent drugs: development, characterization, in vitro permeation, in vivo pharmacokinetic, and molecular dynamics studies. |
2017 |
Int J Nanomedicine |
pmid:29158673
|
Hassan SM et al. |
Protective effects of apigenin and myricetin against cisplatin-induced nephrotoxicity in mice. |
2017 |
Pharm Biol |
pmid:28064632
|